Chronic kidney disease is becoming more generalglobally and is very much linked to the occurrenceof cardiovascular disease (CVD). A lot of people with CKD feel hypertension (HTN), which is both a source and a result of the condition. According to the most recent hypertension recommendations, individuals with well-known CKD and/or diabetes with albuminuria should aim for a blood pressure (BP) goal of less than 130/80 mmHg. People suffering from CKD who have blood pressure more than 130/80 mmHg must change their lifestyles and use many antihypertensive drugs.In persons with CKD, managing HTN is important since it reduces the risk of CVD and decreases the disease's course.As a result, knowing the data used to develop these guidelines is critical for deciding how to effectively care for particular patients.Non-pharmacological treatment can help to decrease blood pressure (BP) in populations with CKD, but they are not enough alone to remain BP under control.Patients withhypertension and CKD may need a mix of antihypertensive medicines to attain their desired blood pressure. Before beginning therapy, it is important to consider the extra BP-independent renoprotective and/or cardio-protectiveaction that some pharmaceuticals give. In future, new treatments may improve therapy. Moreover, meeting BP objectives, lowering CVD risk, and delaying the course of CKD all require a personalised and evidence-based treatment approach.